Damora Therapeutics DMRA
NASDAQ DMRA
$20.66 -0.09 (-0.43%)
At close: Sep 29, 2026 · 4:00 PM EDT

Damora Therapeutics (DMRA) Restructuring Costs (2023 - 2024)

Updated

Damora Therapeutics (DMRA) posted Restructuring Costs of $968,000 for FY2024, down 71.9% from $3.45 million in FY2023.

Analysis

Damora Therapeutics (DMRA) Restructuring Costs (2023 - 2024) Analysis & Trends

  • Business Quant data shows DMRA's Restructuring Costs at $3.45 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Damora Therapeutics 1.28 Bn -57.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 968,000.00
Dec 31, 2023 720,000.00
Sep 30, 2023 2.73 Mn
API Access

Damora Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=DMRA&period=max&api_key=YOUR_API_KEY